Lantheus Holdings, Inc. (LNTH) Financials

LNTH Assets vs Liabilities

DateAssetsLiabilities
2024-03-31 1.8 billion 885.8 million
2023-12-31 1.7 billion 835.3 million
2023-09-30 1.5 billion 822.9 million
2023-06-30 1.3 billion 785.1 million

LNTH Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2024-03-31 119.0 million 15.4 million
2023-12-31 100.2 million 14.2 million
2023-09-30 102.1 million 14.0 million
2023-06-30 -43.0 million 12.7 million

LNTH Net Income

Graph available only for supporters. Become a supporter to see it.
DateNet Income
2024-03-31 131.1 million
2023-12-31 103.4 million
2023-09-30 132.0 million
2023-06-30 94.1 million

LNTH Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2024-03-31 718.3 million - 54.1 million
2023-12-31 713.7 million - 54.5 million
2023-09-30 614.1 million - 54.4 million
2023-06-30 414.1 million 559.2 million 31.3 million

LNTH Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2024-03-31 70.1 million
2023-12-31 70.1 million
2023-09-30 70.0 million
2023-06-30 71.0 million

LNTH Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2024-03-31 8.3 million 48.0 million 47.9 million 45.5 million
2023-12-31 12.1 million 16.8 million 40.3 million 35.3 million
2023-09-30 14.6 million 14.5 million 35.7 million 37.4 million
2023-06-30 10.7 million 15.9 million 26.2 million 36.5 million

LNTH Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2024-03-31 370.0 million 118.2 million
2023-12-31 354.0 million 124.1 million
2023-09-30 319.9 million 120.0 million
2023-06-30 321.7 million 119.1 million

LNTH

Price: $78.22

52 week price:
50.20
100.85

Earnings Per Share: 4.65 USD

P/E Ratio: 36.66

Exchange: NGM

Sector: Healthcare

Industry: Drug Manufacturers - Specialty & Generic

Volume: 24390

Ebitda: 17.5 million

Market Capitalization: 5.3 billion

Links: